- Staat
- WI
- Alter
- 0,4
- Geschlecht
- M
- Eingang
- 15.05.2023
- Impfdatum
- 27.02.2023
- Beginn
- 03.03.2023
- Tage bis Beginn
- 4,0
- Dosis
- 1
- Route/Site
- IM / RL
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Fatigue
Hypersomnia
Illness
Immediate post-injection reaction
Infant irritability
Pyrexia
Symptomtext
The decedent died on 03/03/2023.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Reflux
- Vorgeschichte
- Reflux, born at 32 weeks - 3 lbs 6oz at birth, twin pregnancy.
- Andere Medikamente
- Organic liquid multi-vitamin drops, orange-vanilla flavored
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 1,6
- Geschlecht
- M
- Eingang
- 23.03.2023
- Impfdatum
- 22.03.2023
- Beginn
- 22.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Erythema
Urticaria
Symptomtext
Hives developed on L side of cheek 1 inch x 1.5 inches and R side of cheek- 0.25inch x 0.25 inch about 15 minutes after vaccine administration. other parts of skin: no rash, no anaphylaxis, angioedema, or acute distress. No difficulty breathing. Patient monitored for another 30 minutes and left the center in stable condition. Patient mother advised to bring patient to medical team if worsening or not improving. Also discussed red flags that warrant EMS/ED. VIS form given to the mother and educated on sign and symptoms and side effect of vaccine. treatment: hydrocortisone 1% topical cream. patient was seen by different provider. during that time, patient has Urticaria with erythema noted to bilateral sides of face and upper back. PE-WNL, no other significant findings. treatment: Benadryl allergy 12.5mg/5ml oral liquid- administered 1ml by oral route. vitals were stable and patient was not in acute distress. patient was transported to ER via EMS for further evaluation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- hydrocortisone 1% cream and benadryl oral liquid 1 ml.
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- LA
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 08.02.2023
- Impfdatum
- 06.02.2023
- Beginn
- 06.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Pyrexia
Single component of a two-component product administered
Symptomtext
Patient received the Pentacel vaccine. With the Pentacel vaccine, only the blue top vial containing DTap and IPV were administered to the patient. The green top vial containing the HIB was not mixed with the blue top vial. Pt did not receive the HIB green top vial. Mother contacted the office today, 2/08/2023, to inform us that the patient has been running a fever since Monday after the vaccines were given. Also stated that she brought the patient to an ER today, 2/08/2023, which the staff at the ER informed mom that fever is normal after receiving vaccines.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Ear infection, atopic dermatitis
- Vorgeschichte
- N/a
- Andere Medikamente
- No
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 0,3
- Geschlecht
- F
- Eingang
- 01.02.2023
- Impfdatum
- 12.01.2023
- Beginn
- 23.01.2023
- Tage bis Beginn
- 11,0
- Dosis
- UNK
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Blood culture
C-reactive protein
Coagulation test
Full blood count
Kawasaki's disease
Metabolic function test
Pyrexia
Red blood cell sedimentation rate
Urine analysis
Symptomtext
developed kawaski disease in the 2 weeks following, fevers started day of vaccination
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- 2,0
- Labordaten
- CBC 1/30/23 BMP 1/30/23 coagulation studies 1/30/23 UA 1/30/23 ESR 1/30/23 CRP 1/30/23 Blood cultures 1/30/23
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 0,5
- Geschlecht
- F
- Eingang
- 01.02.2023
- Impfdatum
- 30.01.2023
- Beginn
- 30.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pyrexia
Symptomtext
fever of 103.3
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 0,8
- Geschlecht
- M
- Eingang
- 18.01.2023
- Impfdatum
- 17.01.2023
- Beginn
- 17.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash
Rash macular
Urticaria
Symptomtext
Last night had some light-colored spots before bed. This morning there are red spots/rash that look like hives all over body - not on forehead or scalp. No fever or other symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- milk allergy - vomiting
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 0,2
- Geschlecht
- F
- Eingang
- 09.01.2023
- Impfdatum
- 27.12.2022
- Beginn
- 27.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Macule
Pallor
Rash
Symptomtext
Patient with blanching erythematous macules about 1 cm in size across face, forehead, occiput, and on one heal. No work of breathing. Monitored for 30 minutes and rash resolved.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 0,5
- Geschlecht
- M
- Eingang
- 06.01.2023
- Impfdatum
- 06.01.2023
- Beginn
- 06.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 7+
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pyrexia
Respirovirus test
SARS-CoV-2 test
Vomiting
Symptomtext
After vaccines had a low grade fever. Thursday night had a fever of 103.5 and cough. Fever down with medication and fever gone 1/6/2023. 1 round of vomiting Thursday night, none since. Was seen 1/6/2023 by the doctor and viral testing done.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- Respiratory profile and covid testing
- Aktuelle Erkrankungen
- After vaccines had a low grade fever. Thursday 1/5/23 night had a fever of 103.5 and cough. Fever down with medication and fever gone 1/6/2023
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 0,3
- Geschlecht
- M
- Eingang
- 09.12.2022
- Impfdatum
- 08.12.2022
- Beginn
- 08.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Allergy to vaccine
Hypersensitivity
Rash
Symptomtext
Encounter for vaccination: - AGE 6 WKS-4 YRS DTAP-IPV-HIB-HEP B (DIPH/TET/PERTUS, POLIOVIRUS, HAEMOPH INFL TYPE B, HEP B) VACCINE <VAXELIS> - AGE 0-18 YRS PCV-13 (PNEUMOCOCCAL, 13-VALENT) VACCINE <PREVNAR-13> - AGE 6 - 24 WKS ROTAVIRUS (MONOVALENT) VACCINE <ROTARIX> 12/08/2022 1620 Patient Care Technician was informed in the waiting area by the parent of the child he had developed a rash after the vaccines. Pt. was already discharged. Technician brought patient to an exam room. Charge Nurse was of the development of rash and orders. Pt. developed a rash on forehead, cheeks, and left forearm after administration of vaccines. Due to the allergic reaction to vaccines, pt received diphenhydramine (BENADRYL) 6.25 mg by mouth x1. Pt. alert, BBS present and clear. Pulse ox 99%, HR 138, RR 28. 12/08/2022 1636 Pt. with no distress. Rash had resolved. BBS present and clear.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 0,2
- Geschlecht
- M
- Eingang
- 20.11.2023
- Impfdatum
- 09.11.2023
- Beginn
- 09.11.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Symptomtext
As per CDC guidelines, avoid using two 50mg doses for infants weighing (?11 pounds), because 50mg doses should be reserved only for infants weighing (<11 pounds), for example those born during the season who will be at increased risk for severe RSV illness because of their young age. Furthermore, providers should be aware that some insurers may not cover the cost of two 50mg doses for an individual infant, and health care settings currently experiencing shortages of Beyfortus should prioritize 100mg doses to infants at the highest risk for severe RSV disease. Patient was monitored for 30 minutes after vaccines were administered and did not show any sign of pain, discomfort or adverse reaction. Patient tolerated administration well and was sent home.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- None.
- Andere Medikamente
- Tylenol was given by mother to child before vaccine appointment.
- Allergien
- None.
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 1,8
- Geschlecht
- M
- Eingang
- 11.10.2023
- Impfdatum
- 09.10.2023
- Beginn
- 09.10.2023
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine given had expired on 10/6/2023
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- -
- Geschlecht
- F
- Eingang
- 27.06.2023
- Impfdatum
- 28.02.2023
- Beginn
- 28.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
Patient was given a Varivax in addition to a Pro Quad which contained Varicella; This case was retrieved during monitoring on 12-APR-2023 with the following Primary 2589271-1. The original narrative from the sender is as follows: Patient was given a Varivax in addition to a Pro Quad which contained Varicella. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported event "Patient was given a Varivax in addition to a Pro Quad which contained Varicella". No further information is expected. Based on the available information, the events were not related to Vaxelis but to other vaccines. Vaxelis should have been considered a concomitant, however the case was retrieved and information was kept as reported in the form.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Asthma; Prophylaxis
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- -
- Geschlecht
- M
- Eingang
- 26.06.2023
- Impfdatum
- 03.02.2023
- Beginn
- 02.03.2023
- Tage bis Beginn
- 27,0
- Dosis
- 3
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Circumstance or information capable of leading to medication error
Extra dose administered
Vaccination site erythema
Symptomtext
Vaccination site erythema; Circumstance or information capable of leading to medication error; Extra dose administered; This case was retrieved during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-APR-2023 with the following VAERS Primary 2591946-1. The original narrative from the sender is as follows: Patient here for 12 month well child exam. Originally physician ordered Pentacel, Prevnar and Varivax but after chart review it was determined that child missed the 6 month well child exam and was in need of 3rd dose of Vaxelis. The consent form (paper) had been prepared based on the original orders of Pentacel, Prevnar and Varivax. When the medical assistant asked the MD to sign the order, the MD said (per the MA) we are giving VAXELIS, instead of Varivax. Per the MA, the MD watched the MA cross out VARIVAX and add VAXELIS as well as having the PENTACEL checked off. The MD then signed the order. MA administered the vaccines and upon documentation in the medical record, noted a different set of orders in the chart that DID NOT include the Pentacel but did include the Varivax. The MA did notify the physician and myself right away. The parent was notified of the event and was advised to monitor for increase in fever, irritability, or local reaction. I apologized for the experience and that I would be looking into how this occurred in spite of our careful attention to safety. I gave her my name to call for any additional questions. Parent did bring child to the ED for evaluation about 2 hrs after the incident. ED diagnosis of 'parental concern'. after the dual vaccinations received. Vital signs at that visit WNL with no fever. All other physical exam WNL except for '3 Vaccine sites notes with mild surrounding erythema but no tenderness'. The department on call physician was notified in case there were any further concern overnight which there were not. No subsequent calls were made to the office since then and no further ED evaluations noted. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported events. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Circumstance or information capable of leading to medication error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Prophylaxis
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- -
- Geschlecht
- M
- Eingang
- 26.06.2023
- Impfdatum
- 03.02.2023
- Beginn
- 02.03.2023
- Tage bis Beginn
- 27,0
- Dosis
- UNK
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Circumstance or information capable of leading to medication error
Extra dose administered
Vaccination site erythema
Symptomtext
Vaccination site erythema; Circumstance or information capable of leading to medication error; Extra dose administered; This case was retrieved during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-APR-2023 with the following VAERS Primary 2591946-1. The original narrative from the sender is as follows: Patient here for 12 month well child exam. Originally physician ordered Pentacel, Prevnar and Varivax but after chart review it was determined that child missed the 6 month well child exam and was in need of 3rd dose of Vaxelis. The consent form (paper) had been prepared based on the original orders of Pentacel, Prevnar and Varivax. When the medical assistant asked the MD to sign the order, the MD said (per the MA) we are giving VAXELIS, instead of Varivax. Per the MA, the MD watched the MA cross out VARIVAX and add VAXELIS as well as having the PENTACEL checked off. The MD then signed the order. MA administered the vaccines and upon documentation in the medical record, noted a different set of orders in the chart that DID NOT include the Pentacel but did include the Varivax. The MA did notify the physician and myself right away. The parent was notified of the event and was advised to monitor for increase in fever, irritability, or local reaction. I apologized for the experience and that I would be looking into how this occurred in spite of our careful attention to safety. I gave her my name to call for any additional questions. Parent did bring child to the ED for evaluation about 2 hrs after the incident. ED diagnosis of 'parental concern'. after the dual vaccinations received. Vital signs at that visit WNL with no fever. All other physical exam WNL except for '3 Vaccine sites notes with mild surrounding erythema but no tenderness'. The department on call physician was notified in case there were any further concern overnight which there were not. No subsequent calls were made to the office since then and no further ED evaluations noted. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported events. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Circumstance or information capable of leading to medication error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Prophylaxis
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 14,0
- Geschlecht
- M
- Eingang
- 12.06.2023
- Impfdatum
- 30.05.2023
- Beginn
- 30.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
Symptomtext
Prevnar 13 was not ordered, but was administered on May 30th, 2023. No symptoms or treatment required. patient guardian was contacted by physician.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 18.05.2023
- Impfdatum
- 16.05.2023
- Beginn
- 16.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
Patient received an expired Pentacel. Health dept was called and provider made aware. Patient to return to office for redose. No acute reaction or adverse signs/symptoms reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None reported.
- Vorgeschichte
- None reported.
- Andere Medikamente
- None reported.
- Allergien
- NKDA.
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- -
- Geschlecht
- M
- Eingang
- 07.04.2023
- Impfdatum
- 06.12.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's; This spontaneous safety report, with reference number 02299086 (Interaction # 02299043) was received by the partner on 19-DEC-2022 and forwarded on 21-DEC-2022, from a health professional. Due to the nature of the event, the causality between the event "HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's" and Vaxelis was not applicable. Further information is expected. For reference purposes, this case is linked to MCM-004406, MCM-004408, MCM-004409 and MCM-004410 (same reporter). SIGNIFICANT FOLLOW UP INFORMATION was received on 03-JAN-2023 from the health care professional. The reporter confirmed that there were no Adverse Events following Vaxelis administration to the patient. Due to the nature of the event, the causality between the event "HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's" and Vaxelis remains not applicable. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Prophylaxis (Birth Weight 7lb (pounds) 11 oz (ounces))
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- -
- Geschlecht
- F
- Eingang
- 04.04.2023
- Impfdatum
- 06.12.2022
- Beginn
- 01.12.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's; This spontaneous safety report, with reference number 02299086 (Interaction # 02299043) was received by the partner on 19-DEC-2022 and forwarded on 21-DEC-2022, from a health professional. Due to the nature of the event, the causality between the event "HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's" and Vaxelis was not applicable. Further information is expected. For reference purposes, this case is linked to MCM-004406, MCM-004408, MCM-004409 and MCM-004407 (same reporter). SIGNIFICANT FOLLOW UP INFORMATION was received on 03-JAN-2023 from the health care professional. The reporter confirmed that there were no Adverse Events following Vaxelis administration to the patient. Due to the nature of the event, the causality between the event "HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's" and Vaxelis remains not applicable. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Prophylaxis
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- -
- Geschlecht
- M
- Eingang
- 04.04.2023
- Impfdatum
- 05.12.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's; This spontaneous safety report, with reference number 02299086 (Interaction # 02299043) was received by the partner on 19-DEC-2022 and forwarded on 21-DEC-2022, from a health professional. Due to the nature of the event, the causality between the event "HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's" and Vaxelis was not applicable. Further information is expected. For reference purposes, this case is linked to MCM-004406, MCM-004408, MCM-004407 and MCM-004410 (same reporter). SIGNIFICANT FOLLOW UP INFORMATION was received on 03-JAN-2023 from the health care professional. The reporter confirmed that there were no Adverse Events following Vaxelis administration to the patient. Due to the nature of the event, the causality between the event "HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's" and Vaxelis remains not applicable. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Prophylaxis (Birth Weight: 7lb (pounds) 10z (ounces))
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- -
- Geschlecht
- F
- Eingang
- 04.04.2023
- Impfdatum
- 06.12.2022
- Beginn
- 01.12.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's; This spontaneous safety report, with reference number 02299086 (Interaction # 02299043) was received by the partner on 19-DEC-2022 and forwarded on 21-DEC-2022, from a health professional. Due to the nature of the event, the causality between the event "HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's" and Vaxelis was not applicable. Further information is expected. For reference purposes, this case is linked to MCM-004406, MCM-004407, MCM-004409 and MCM-004410 (same reporter). SIGNIFICANT FOLLOW UP INFORMATION was received on 03-JAN-2023 from the health care professional. The reporter confirmed that there were no Adverse Events following Vaxelis administration to the patient. Due to the nature of the event, the causality between the event "HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's" and Vaxelis remains not applicable. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Prophylaxis (Birth Weight: 6 lb (pounds) 14 oz (ounces))
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- -
- Geschlecht
- F
- Eingang
- 04.04.2023
- Impfdatum
- 05.12.2022
- Beginn
- 01.12.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's; This spontaneous safety report, with reference number 02299086 (Interaction # 02299043) was received by the partner on 19-DEC-2022 and forwarded on 21-DEC-2022, from a health professional Due to the nature of the event, the causality between the event "HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's" and Vaxelis was not applicable. Further information is expected. For reference purposes, this case is linked to MCM-004407, MCM-004408, MCM-004409 and MCM-004410 (same reporter). SIGNIFICANT FOLLOW UP INFORMATION was received on 03-JAN-2023 from the health care professional. The reporter confirmed that there were no Adverse Events following Vaxelis administration to the patient. Due to the nature of the event, the causality between the event "HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's" and Vaxelis remains not applicable. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Prophylaxis (Birth Weight 6 pounds (lb) 4 oz (ounces))
- Vorgeschichte
- Medical History/Concurrent Conditions: Failure to thrive; GERD; Lactose intolerance; Plagiocephaly; Torticollis; Weight gain poor
- Andere Medikamente
- FAMOTIDINE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 03.04.2023
- Impfdatum
- 28.03.2023
- Beginn
- 03.04.2023
- Tage bis Beginn
- 6,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
patient requested the PCV13 vaccine that was listed on the paperwork provided to him from his surgeon. Nurse administered this vaccine before realizing that they no longer recommends PCV13 for adults. The patient should have received PCV20. No adverse reactions or side effects occurred.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 03.04.2023
- Impfdatum
- 28.03.2023
- Beginn
- 28.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Wrong product administered
Symptomtext
patient requested the PCV13 vaccine that was listed on the paperwork provided to him from his surgeon. Nurse administered this vaccine before realizing that they no longer recommends PCV13 for adults. The patient should have received PCV20. No adverse reactions or side effects occurred.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 2,0
- Geschlecht
- F
- Eingang
- 01.03.2023
- Impfdatum
- 28.02.2023
- Beginn
- 28.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
Patient was given a Varivax in addition to a Pro Quad which contained Varicella
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None known
- Vorgeschichte
- Asthma
- Andere Medikamente
- None known
- Allergien
- None known
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- U
- Eingang
- 15.02.2023
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Syringe issue
Symptomtext
1 dose that was broken, the syringe; The initial case was missing the following minimum criteria: adverse event. Upon receipt of follow-up information on 30Jan2023, this case now contains all required information to be considered valid. This is a spontaneous report received from a contactable reporter(s) (Nurse) from product quality group. A patient (no qualifiers provided) received pneumococcal 13-val conj vac (dipht CRM197 protein) (PREVNAR 13), as dose number unknown, single (Lot number: FN5555, Expiration Date: 31Jul2024) for immunisation, Device Lot Number: FN5555, Device Expiration Date: 31Jul2024. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SYRINGE ISSUE (non-serious), outcome "unknown", described as "1 dose that was broken, the syringe". Additional information: NDC number of Prevnar 13: 0005197101. According to the nurse, the received a Prevnar 13, 1 dose that was broken, the syringe. They received a damaged box, just 1 syringe was damaged in the shipment. When probed if the syringe was used on any patient: Nurse stated, "No".
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syringe issue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 07.02.2023
- Impfdatum
- 04.02.2023
- Beginn
- 04.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect dose administered
Symptomtext
Accidental double dose of varicella vaccine given.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 0,3
- Geschlecht
- M
- Eingang
- 02.02.2023
- Impfdatum
- 01.02.2023
- Beginn
- 02.02.2023
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Wrong product administered
Symptomtext
Pt. was administered Kinrix instead of Pediarix.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- plagiocephaly
- Vorgeschichte
- plagiocephaly
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- 0,4
- Geschlecht
- M
- Eingang
- 16.01.2023
- Impfdatum
- 04.01.2023
- Beginn
- 04.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
Temp. excursion lasted 13h-35.7?F, Vx administered; This case was reported by a other health professional via other manufacturer and described the occurrence of incorrect storage of drug in a 5-month-old male patient who received Rota (Rotarix lyophilized formulation) (batch number 7L2D7, expiry date 24th February 2024) for prophylaxis. Co-suspect products included rotavirus vaccine oral applicator device (Rotarix Oral Applicator Device) oral applicator for prophylaxis and PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) (batch number FN5555, expiry date unknown) for prophylaxis. Additional patient notes included None. On 4th January 2023, the patient received Rotarix lyophilized formulation (oral), Rotarix Oral Applicator Device and the 2nd dose of PREVNAR 13 (intramuscular) .5 ml. On 4th January 2023, unknown after receiving Rotarix lyophilized formulation and Rotarix Oral Applicator Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 06-JAN-2023 Reporter's comment: The reporter was certified MA (Medical assistant) called on behalf of facility. The reporter weight was 17 pounds, 14 ounces. The patient had no family medical history relevant to adverse event. The patient was not vaccinated with prior vaccinations (within 4 weeks). The reporter was reporting that they had given Rotarix and Prevnar 13 to patient after temperature excursion. The patient was administered with Prevnar 13 at appropriate age to get second dose. The temperature excursion lasted 13 hours and lowest temperature reached was 35.7 degrees Fahrenheit. The reporter clarified that 2 patients received the vaccines involved in the temperature excursion. Additional Vaccine administered on the same date of the Pfizer suspect. The patient was not required emergency room visit. The was not visited to physician office. Additional Supportive Information: The reporter was reporting that they had given Rotarix and Prevnar 13 to patient after temperature excursion, which led to incorrect storage of drug. The case had been linked to US2023AMR002404, reported by the same reporter, for a different patient. As clarification was raised to confirm the vaccination date and event onset date, the vaccination date and event onset date were captured 4th January 2023 from the narrative conservatively.; Sender's Comments: US-GSK-US2023AMR002404:Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: None
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 11.01.2023
- Impfdatum
- 10.01.2023
- Beginn
- 10.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
Provider ordered Prevnar 20 from adult stock. Medical assistant gave Prevnar 13 from pediatric stock.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- GERD, chronic kidney disease stage 3, tobacco use, hypertension, elevated liver enzymes, orthopnea, hyperlipidemia, diabetes type 2, diabetic neuropathy
- Andere Medikamente
- amlodipine 10mg daily lovastatin 80mg daily metoprolol 100mg ER daily pantoprazole 20mg daily pregabalin 150mg BID fenofibrate 48mg 2 tablets daily furosemide 20mg every other day calcitriol 0.25mcg capsule 3x/week humalog insulin 45 units
- Allergien
- atorvastatin (myalgia) gemfibrozil (rash) lisinopril (cough) niacin (unknown reaction)
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 0,2
- Geschlecht
- F
- Eingang
- 05.01.2023
- Impfdatum
- 18.10.2022
- Beginn
- 05.01.2023
- Tage bis Beginn
- 79,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Unevaluable event
Symptomtext
There were no adverse events reported and patient's parents were contacted
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 0,2
- Geschlecht
- F
- Eingang
- 05.01.2023
- Impfdatum
- 18.10.2022
- Beginn
- 05.01.2023
- Tage bis Beginn
- 79,0
- Dosis
- 1
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Unevaluable event
Symptomtext
There were no adverse events reported and patient's parents were contacted
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 1,5
- Geschlecht
- M
- Eingang
- 04.01.2023
- Impfdatum
- 06.12.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
temperature excursion; No additional AEs; This spontaneous report was received from a registered nurse and refers to an 18-month-old male patient. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 06-DEC-2022, the patient was vaccinated with improperly stored doses of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) intramuscular injection, lot #W006595, expiration date: 10-OCT-2024, administered intramuscularly for prophylaxis (dose and strength were not provided); pneumococcal vaccine conj (PCV B) lot #FN5555, expiration date: 31-JUL-2024, administered intramuscularly (dose, strength, formulation, and indication were not provided); hepatitis a vaccine inact (HAVRIX), unk, lot #94H52, expiration date: 30-APR-2023, administered intramuscularly (strength, formulation, and indication were not provided); and diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (DTAP) lot #Y4259, expiration date: 03-MAR-2024, administered intramuscularly (dose, strength, formulation, and indication were not provided) (product storage error). On an unknown date, before the administration, the vaccines underwent temperature excursion for unknown period of time. There was no adverse event reported. The reporter considered temperature excursion to be not related to suspect vaccines.; Sender's Comments: US-009507513-2212USA007828: US-009507513-2212USA007829: US-009507513-2212USA007830: US-009507513-2212USA007831: US-009507513-2212USA007832: US-009507513-2212USA007833: US-009507513-2212USA007834: US-009507513-2212USA007835: US-009507513-2212USA007836: US-009507513-2212USA007837: US-009507513-2212USA003061:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 2,0
- Geschlecht
- F
- Eingang
- 30.12.2022
- Impfdatum
- 30.12.2022
- Beginn
- 01.12.2022
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
Symptomtext
Patient was at clinic with mom getting catch-up vaccines. Vaccine was ordered correctly on chart. MA when to look for vaccines and did not realize it was the adult vaccine vs. the pediatric vaccine. Administered adult vaccine instead of pediatric
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 30.12.2022
- Impfdatum
- 06.12.2022
- Beginn
- 06.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs; temperature excursion; This spontaneous report was received from a registered nurse and refers to a 12-month-old male patient. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 06-DEC-2022, the patient was vaccinated with improperly stored doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant human albumin (rHA) (M-M-R II) subcutaneous injection, lot #U039549, expiration date: 14-DEC-2023, administered subcutaneously for prophylaxis (dose and strength were not provided); varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #W018825, expiration date: 14-JUN-2024, administered subcutaneously for prophylaxis (dose and strength were not provided); pneumococcal vaccine conj (PCV 13) lot #FN5555, expiration date: 31-JUL-2024, administered intramuscularly (strength, dose, formulation, and indication were not provided); and hepatitis a vaccine inact (HAVRIX) lot #94H52, expiration date: 30-NOV-2023, administered intramuscularly (strength, dose, formulation, and indication were not provided) (product storage error). On an unknown date, before the administration, the vaccines underwent temperature excursion for unknown period of time. There was no adverse event reported. The reporter considered temperature excursion to be not related to suspect vaccines.; Sender's Comments: US-009507513-2212USA007828: US-009507513-2212USA007829: US-009507513-2212USA007830: US-009507513-2212USA007831: US-009507513-2212USA007832: US-009507513-2212USA007833: US-009507513-2212USA007834: US-009507513-2212USA007836: US-009507513-2212USA007837: US-009507513-2212USA007838: US-009507513-2212USA003061:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 0,5
- Geschlecht
- F
- Eingang
- 23.12.2022
- Impfdatum
- 06.12.2022
- Beginn
- 06.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs; temperature excursion; This spontaneous report was received from a registered nurse and refers to a 6-month-old female patient. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 06-DEC-2022, the patient was vaccinated with improperly stored doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, lot #1892790, expiration date: 03-DEC-2023, administered orally for prophylaxis (strength and dose were not provided); diphtheria toxoid (+) hepatitis b virus vaccine rhbsag (yeast) (+) hib conj vaccine (ompc) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid (VAXELIS) injection, lot #U7205AA, expiration date: 23-OCT-2024, administered intramuscularly for prophylaxis (strength and dose were not provided); and pneumococcal vaccine conj (PCV 13) lot #FN5555, expiration date: 31-JUL-2024, administered intramuscularly (strength, dose, formulation, and indication were not provided) (product storage error). On an unknown date, before the administration, the vaccines underwent temperature excursion for unknown period of time. There was no adverse event reported. The reporter considered temperature excursion to be not related to suspect vaccines.; Sender's Comments: US-009507513-2212USA007828: US-009507513-2212USA007829: US-009507513-2212USA007830: US-009507513-2212USA007831: US-009507513-2212USA007832: US-009507513-2212USA007833: US-009507513-2212USA007834: US-009507513-2212USA007835: US-009507513-2212USA007836: US-009507513-2212USA007837: US-009507513-2212USA007838:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 0,5
- Geschlecht
- M
- Eingang
- 23.12.2022
- Impfdatum
- 05.12.2022
- Beginn
- 05.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
No additional AEs; temperature excursion; This spontaneous report was received from a registered nurse and refers to a 6-month-old male patient. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 05-DEC-2022, the patient was vaccinated with improperly stored doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, lot #1892790, expiration date: 03-DEC-2023, administered orally for prophylaxis (strength and dose were not provided); diphtheria toxoid (+) hepatitis b virus vaccine rhbsag (yeast) (+) hib conj vaccine (ompc) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid (VAXELIS) injection, lot #U7205AA, expiration date: 23-OCT-2024, administered intramuscularly for prophylaxis (strength and dose were not provided); and pneumococcal vaccine conj (PCV 13) lot #FN5555, expiration date: 31-JUL-2024, administered intramuscularly (strength, dose, formulation, and indication were not provided) (product storage error). On an unknown date, before the administration, the vaccines underwent temperature excursion for unknown period of time. There was no adverse event reported. The reporter considered temperature excursion to be not related to suspect vaccines.; Sender's Comments: US-009507513-2212USA007828: US-009507513-2212USA007829: US-009507513-2212USA007830: US-009507513-2212USA007831: US-009507513-2212USA007832: US-009507513-2212USA007833: US-009507513-2212USA007834: US-009507513-2212USA007835: US-009507513-2212USA007836: US-009507513-2212USA007837: US-009507513-2212USA007838:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 0,3
- Geschlecht
- F
- Eingang
- 23.12.2022
- Impfdatum
- 06.12.2022
- Beginn
- 06.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Product storage error
Symptomtext
No additional AEs; temperature excursion; Inappropriate age at vaccine administration; This spontaneous report was received from a registered nurse and refers to a 19 weeks old female patient. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 06-DEC-2022, the patient was vaccinated with improperly stored doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, lot #1892790, expiration date: 03-DEC-2023, administered orally for prophylaxis (strength and dose were not provided); diphtheria toxoid (+) hepatitis b virus vaccine rhbsag (yeast) (+) hib conj vaccine (ompc) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid (VAXELIS) injection, lot #U7205AA, expiration date: 23-OCT-2024, administered intramuscularly for prophylaxis (strength and dose were not provided); and pneumococcal vaccine conj (PCV 13) lot #FN5555, expiration date: 31-JUL-2024, administered intramuscularly (strength, dose, formulation, and indication were not provided) (product storage error, product administered to patient of inappropriate age). On an unknown date, before the administration, the vaccines underwent temperature excursion for unknown period of time. There was no adverse event reported. The reporter considered temperature excursion to be not related to suspect vaccines.; Sender's Comments: US-009507513-2212USA007828:Same Reporter US-009507513-2212USA007829:Same Reporter US-009507513-2212USA007830:Same Reporter US-009507513-2212USA007831:Same Reporter US-009507513-2212USA007838:Same Reporter US-009507513-2212USA007833:Same Reporter US-009507513-2212USA007834:Same Reporter US-009507513-2212USA007835:Same Reporter US-009507513-2212USA007836:Same Reporter US-009507513-2212USA007837:Same Reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 0,5
- Geschlecht
- F
- Eingang
- 23.12.2022
- Impfdatum
- 05.12.2022
- Beginn
- 05.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs; temperature excursion; This spontaneous report was received from a registered nurse and refers to a 6-month-old female patient. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 05-DEC-2022, the patient was vaccinated with improperly stored doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, lot #1892790, expiration date: 03-DEC-2023, administered orally for prophylaxis (strength and dose were not provided); diphtheria toxoid (+) hepatitis b virus vaccine rhbsag (yeast) (+) hib conj vaccine (ompc) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid (VAXELIS) injection, lot #U7205AA, expiration date: 23-OCT-2024, administered intramuscularly for prophylaxis (strength and dose were not provided); and pneumococcal vaccine conj (PCV 13) lot #FN5555, expiration date: 31-JUL-2024, administered intramuscularly (strength, dose, formulation, and indication were not provided) (product storage error). On an unknown date, before the administration, the vaccines underwent temperature excursion for unknown period of time. There was no adverse event reported. The reporter considered temperature excursion to be not related to suspect vaccines.; Sender's Comments: US-009507513-2212USA007828: US-009507513-2212USA007829: US-009507513-2212USA007830: US-009507513-2212USA007831: US-009507513-2212USA007832: US-009507513-2212USA007833: US-009507513-2212USA007834: US-009507513-2212USA007835: US-009507513-2212USA007836: US-009507513-2212USA007837: US-009507513-2212USA007838:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 0,8
- Geschlecht
- M
- Eingang
- 09.11.2022
- Impfdatum
- 09.11.2022
- Beginn
- 09.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Symptomtext
extra doses given to patient. documentation error noted after given that third dose was not correctly documented so it did not show up in our records
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 2,0
- Geschlecht
- F
- Eingang
- 03.11.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Unevaluable event
Symptomtext
On 10/27/2022, the provider ordered a 4th Prevnar vaccine because the patient had only received 3 Prevnar doses. However the fourth dose of the Prevnar was not necessary because the patient had already received one dose after the age of 1.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -